https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:43667 Wed 28 Sep 2022 13:52:58 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:40457 Wed 27 Jul 2022 11:14:03 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:42676 Wed 22 Mar 2023 14:34:07 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51029 Wed 16 Aug 2023 10:09:44 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:16820 Wed 11 Apr 2018 12:28:20 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:36591 Wed 10 Jun 2020 14:23:24 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49020 Wed 03 May 2023 12:31:22 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:43097 Tue 13 Sep 2022 12:40:26 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:33388 Tue 03 Sep 2019 17:54:11 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:561 Thu 25 Jul 2013 09:10:39 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:542 Thu 25 Jul 2013 09:10:24 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:8429 Sat 24 Mar 2018 08:40:48 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:8132 Sat 24 Mar 2018 08:40:03 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:1772 Sat 24 Mar 2018 08:27:35 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:16020 0.46, p<0.05). Conclusions: Older schizophrenia patients show a peculiar pattern of CSF Abeta42 and tau concentrations that relates to cognitive and structural markers but is not consistent with neurodegeneration and could be secondary to neurodevelopmental or drug treatment effects.]]> Sat 24 Mar 2018 08:19:31 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:10763 Sat 24 Mar 2018 08:13:54 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:12248 11). The cortex displayed up to 20% reduction in the orbitofrontal and midline structures (corrected p<0.001 bilaterally). Up to 30% tissue reduction in the basolateral nucleus, and 10–30% enlargement effects in the central and lateral nuclei indicated abnormal structure of the amygdala (corrected p=0.05 on the right; and symmetrical pattern on the left). Psychopathy features specific morphology of the main cerebral structures involved in cognitive and emotional processing, consistent with clinical and functional data, and with a hypothesis of an alternative evolutionary brain development.]]> Sat 24 Mar 2018 08:08:09 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:17539 Sat 24 Mar 2018 08:03:58 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:17935 0.29). Hippocampal surface analysis showed the typical pattern of CA1 and subicular tissue atrophy in both ε4-carriers and non-carriers compared with controls (e4 carriers: p < 0.0002; ε4 non-carriers: p < 0.01, permutation test). The left hippocampal volume was significantly smaller in ε4-carriers than non-carriers (p = 0.044, Mann–Whitney test), the effect of APOE4 mapping to the subicular/CA1 region (p = 0.041, permutation test). Differences were not statistically significant in the right hippocampus (p > 0.20, permutation test). These findings show that hippocampal atrophy is greater in APOE4 carriers in regions typically affected by pathology. APOE4 may affect the structural expression of Alzheimer's disease.]]> Sat 24 Mar 2018 07:56:34 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:20972 Sat 24 Mar 2018 07:54:21 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:26994 Sat 24 Mar 2018 07:25:51 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50977 Mon 14 Aug 2023 15:24:38 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51931 1.5 SD) in SA, 118 (7.47%) in CT and 161 (10.20%) in SV. Psychosis transition was not significantly associated with any measure of heterogeneity. Overall, our examination of neuroanatomical heterogeneity within the CHR-P state indicated greater divergence in neuroanatomical profiles at an individual level, irrespective of psychosis conversion. Further large-scale investigations are required of those who demonstrate marked deviation.]]> Fri 22 Sep 2023 11:07:30 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51559 Fri 08 Sep 2023 16:29:26 AEST ]]>